The American Diabetes Association’s bold transformational initiative,
Pathway to Stop Diabetes, aims to inspire a new generation of diabetes researchers. Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management and cures.
This call for nominations prioritizes translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The Foundation’s ideal applicant will propose innovative research that will be an important step towards improving the lives of people at risk of diabetes or living with the disease and the pathway to this impact is clear.
FUNDING INFORMATION: Up to $1,625,000 with different foci depending on the type of award, as listed below.
- Initiator Award: Up to seven years – up to two years in Phase I and up to five years in Phase II
- Phase I: Up to $100,000 per year with up to 10% of direct costs
- Phase II: Up to $325,000 per year with up to 30% of direct costs
- Accelerator Award: Up to five years. Up to $325,000 per year with up to 30% of direct costs.
ELIGIBILITY: Applicants must have US work authorization.
Initiator Award applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant.
Accelerator Award applicants should be early-career investigators holding faculty positions and having demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award.
INTERNAL SELECTION PROCESS: BU may forward up to two nominations: one nomination spanning basic through preclinical research and one nomination spanning clinical through public health research. Please see page one of this information document for information about each category.
Interested BUMC faculty should submit the following materials listed below via InfoReady Review by Wednesday, May 28, 2025. If you are a faculty who works in BMC space or your research mentor is a BMC investigator and you wish to apply, please contact the Director of Strategic Research Growth Jessica Howard, at Jessica.howard@bmc.org, by Monday, May 19, 2025.
- Short questions outlined in InfoReady Review.
- Two-page research strategy summary describing your scientific question(s), the strategies and approaches used to address the question(s), significance, and potential risks and challenges. References may be listed on a third page.
- Up-to-date CV or biosketch.
As necessary, a faculty committee drawn from both campuses will review the applications and select the institutional nominees.
DEADLINES:
- Internal Deadline: Wednesday, May 28, 2025 by 11:59 p.m. EST
- Anticipated Notification Date: Friday, June 13, 2025
- Application Deadline: Wednesday, July 23, 2025
In requesting to be considered for this limited submission funding opportunity, you are making a commitment, if selected, to submit your proposal to the sponsor in a timely manner and to Sponsored Programs in accordance with the Proposal Submission Policy.
BACK TO TOP↑